|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01099 SINOPHARM
Nominal 
19.010 +0.240 (+1.279%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 11,546,015 | 17,173,030 | 20,963,787 | 9,308,085 |
| Net Cash from / (used in) Investing Activities | -- | (3,750,925) | (944,535) | (3,589,622) | (1,266,962) |
| Net Cash from / (used in) Financing Activities | -- | (17,285,034) | (7,643,970) | (5,693,481) | (14,693,007) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (9,489,944) | 8,584,525 | 11,680,684 | (6,651,884) |
| Cash & Cash Equivalents at beginning of period | -- | 63,808,538 | 55,221,624 | 43,529,428 | 50,178,265 |
| Effect of Foreign Exchange Rate Changes | -- | (5,235) | 2,389 | 11,512 | 3,047 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 54,313,359 | 63,808,538 | 55,221,624 | 43,529,428 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,465,686 |
| %Change | -6.431% |
| EPS / (LPS) | RMB 1.110 |
| NBV Per Share (¥) | RMB 25.710 |